JELDROP
DEAD

Serial Number

97576367

Owner

AiViva Biopharma, Inc.

Attorney

Joe McKinney Muncy

Filing Date

Sep 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

JELDROP Trademark

Serial Number: 97576367

JELDROP is a trademark filed by AiViva Biopharma, Inc. on September 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

AiViva Biopharma, Inc. (3 trademarks)

Suite 101
Dover, DE 19904

Entity Type: 03

Trademark Details

Filing Date

September 2, 2022

Registration Date

Not Registered

Goods & Services

Glaucoma agents; Irrigating solutions for eye use; Medicated eye washes; Eye drops; Ocular pharmaceuticals; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Dermatological pharmaceutical products; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated skin preparation for use in treating wound healing; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Medicinal creams for skin care; Frostbite salve for pharmaceutical purposes; Poultices; Gelatine for medical purposes; Ointments for wound healing; Sunburn ointments; Acne treatment preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gel that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for prostatic diseases and conditions; Pharmaceutical preparations for benign prostatic hyperplasia; Pharmaceutical preparations for the treatment and prevention of prostatic diseases and conditions; Pharmaceutical preparations for the treatment and prevention of benign prostatic hyperplasia

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 1, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 1, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 22, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 22, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 15, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 15, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 15, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 11, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 11, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 11, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2022 NWOS
NEW APPLICATION ENTERED
Sep 6, 2022 NWAP